Type 1 and type 2 diabetes, insulin resistance, glucose metabolism, and metabolic health
266 articles
New research reveals how diabetes and obesity trigger bone inflammation and disrupt key signaling pathways, increasing fracture risk in older women.
New research reveals cardiovascular-kidney-metabolic syndrome stages predict cancer risk through inflammatory pathways.
Advanced incretin-based therapies show potential for major weight loss while protecting heart, kidney, liver, and brain health.
Scientists identify how a metabolic enzyme drives kidney inflammation in diabetes, opening doors for targeted therapies.
Breakthrough study reveals sepiapterin dramatically outperforms existing PKU therapy, offering hope for better metabolic control.
24-month study reveals distinct predictors for diabetes-related distress versus depression, suggesting different treatment approaches needed.
New approach to Type 1 diabetes screening emphasizes patient partnership over traditional medical paternalism.
New framework emphasizes clinician-patient collaboration for early detection and management of chronic beta cell failure.
New study shows dairy proteins combined with structured eating schedule enhances circadian rhythms and glucose control in diabetics.
Researchers advocate for collaborative screening models that empower patients in early diabetes detection decisions.
Breakthrough modulator therapies are changing how doctors diagnose and treat diabetes in cystic fibrosis patients worldwide.
Study shows adults under 35 achieve diabetes remission 3x faster than older patients following gastric bypass surgery.
